SOLICITATION NOTICE
76 -- Renewal to ECRI products - SOW
- Notice Date
- 8/31/2009
- Notice Type
- Combined Synopsis/Solicitation
- NAICS
- 511199
— All Other Publishers
- Contracting Office
- Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services, 5630 Fishers Lane, Room 2129, Rockville, Maryland, 20857-0001
- ZIP Code
- 20857-0001
- Solicitation Number
- FDA-SOL-09-1063419
- Archive Date
- 9/19/2009
- Point of Contact
- Matthew J. Erbe, Phone: 3018277169, Jose Bumbray,
- E-Mail Address
-
matthew.erbe@fda.hhs.gov,
(matthew.erbe@fda.hhs.gov, /div)
- Small Business Set-Aside
- N/A
- Description
- SOW This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. Solicitation number FDA-SOL-09-1063419 is being issued as a request for quote; however, if no response is received to this notice by the response due date, the Food and Drug Administration will issue a sole source award to ECRI for HTAIS and HDgold procducts. The solicitation documents and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2005-36. Background- The FDA Biosciences Library wishes to renew access to content available from ECRI - ECRI Health Technology Assessment Service (HTAIS) and Health Devices (HD) Gold content for five users. ECRI Institute provides unbiased, evidence-based research, testing, investigations, information, planning, and advice on the health care industry. SEE ATTACHMENT CCR: Vendors must be registered in the Central Contractor Registration (CCR) prior to the award of the contract. You may register by going to www.ccr.gov QUESTIONS DEADLINE: All questions are to be submitted via email to Matthew.Erbe@fda.hhs.gov, no later September 2, 2009, 11:00 am EDT. QUOTATIONS DUE: All quotations are due to: Matthew.Erbe@fda.hhs.gov, no later than 3:30 pm, EDT on September 4, 2009. PROVISIONS and CLAUSES: The provision at FAR 52.212-1, Instructions to Offerors Commercial Items applies to this solicitation. The following agenda has been attached to this provision: None. The clause at FAR 52.212-4, Contract Terms and Conditions, Commercial Items applies to this acquisition. The following agenda has been attached to the clause: None. The clause at FAR 52.212-5 Contract Terms and Conditions Required to Implement Statues or Executive Orders, Commercial Items applies to this acquisition. The following FAR clauses cited are applicable: FAR 52.217-8, FAR 52.222-26, FAR 52.222-35, FAR 52.222-36, FAR 52.232-33, FAR 52.246-9 and FAR 52.246-18. Clauses and provisions are incorporated by reference and apply to this acquisition. Responses to this notice shall be sent via email to Matthew.Erbe@fda.hhs.gov
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/FDA/DCASC/FDA-SOL-09-1063419/listing.html)
- Place of Performance
- Address: FDA Biosciences Library, WO2, Room 3051, 10903 New Hampshire Avenue, Silver Spring, Maryland, 20993, United States
- Zip Code: 20993
- Zip Code: 20993
- Record
- SN01933806-W 20090902/090901000815-13c4b3fd991f3130c6fee1e9bd20cd97 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |